Arcutis Biotherapeutics
ARQT
$8.47
Share price
-1.40%
Change (1 day)
-38.44%
Change (1 year)
Categories
Arcutis Biotherapeutics (ARQT) - Cash on Hand
Cash on Hand as of December 2023 : $0.27 B
According to Arcutis Biotherapeutics's latest financial reports the company has $0.27 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arcutis Biotherapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | -33.63% |
| 2022-12-31 | $0.40 B | 5.82% |
| 2021-12-31 | $0.38 B | 36.08% |
| 2020-12-31 | $0.28 B | 180.89% |
| 2019-12-31 | $0.10 B | 98.79% |
| 2018-12-31 | $50.94 M | 1390.35% |
| 2017-12-31 | $3.41 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -23.42% | 🇺🇸 USA |